J.
Average Revenue Per User (ARPU)HealthTechSeries A

Average Revenue Per User (ARPU) for HealthTech at Series A

2026 data · Sample size: 114 · Source: KeyBanc SaaS Survey 2025
25th %ile
$204
Median
$321
75th %ile
$453
90th %ile
$643
▲Trending up year-over-year

About This Metric

Average monthly or annual revenue generated per active user or account.

Total Revenue / Active Users

Higher is better · Unit: currency

How to Improve

Implement value‑based pricing that ties cost to the outcomes customers achieve. Launch premium tier features that justify higher price points. Introduce usage‑based pricing components that grow with customer consumption. Bundle complementary features into higher‑tier packages. Cross‑sell additional products within your portfolio to existing accounts.

Ehsan's Analysis

HealthTech ARPU spans a wider range than any other vertical: $5/month for consumer wellness apps to $50,000+/month for enterprise clinical platforms. The median is meaningless — what matters is the relationship between ARPU and the clinical/business value your product delivers. A radiology AI tool that saves 15 minutes per scan for a radiologist billing $300/hour saves $75/scan. If the hospital processes 1,000 scans/month, the value created is $75,000/month. Pricing at $5,000/month (7% of value) is underpriced. Pricing at $50,000/month (67% of value) is aggressive but defensible. The healthtech ARPU framework: quantify the clinical time saved OR revenue generated by your product, and price at 15-25% of that value. This "value-based pricing" is standard in pharma but rarely applied to healthtech software, where founders default to SaaS-style per-seat pricing that dramatically undervalues their clinical impact.

J.

Ehsan Jahandarpour

AI Growth Strategist & Fractional CMO · Forbes Top 20 Growth Hacker · TEDx Speaker · 716 Academic Citations

Frequently Asked Questions

What is a good Average Revenue Per User (ARPU) for HealthTech companies at Series A stage?
The median Average Revenue Per User (ARPU) for HealthTech companies at the Series A stage is $321. Top‑quartile companies (75th percentile) significantly outperform this baseline. The most important factor is consistent improvement over time rather than hitting any single target number.
How does Average Revenue Per User (ARPU) differ by company stage in HealthTech?
Average Revenue Per User (ARPU) typically increases as HealthTech companies mature from seed through growth stage. Earlier‑stage companies should benchmark against stage‑appropriate peers rather than comparing themselves to mature companies.
How often should HealthTech companies measure Average Revenue Per User (ARPU)?
HealthTech companies at the Series A stage should track Average Revenue Per User (ARPU) monthly with quarterly deep‑dive analysis. Set up automated dashboards and alerts for significant deviations from your baseline.
What factors most impact Average Revenue Per User (ARPU) in the HealthTech sector?
In HealthTech, the primary factors impacting Average Revenue Per User (ARPU) include product‑market fit maturity, competitive landscape intensity, customer segmentation strategy, pricing optimization, and operational efficiency. Series A‑stage companies should focus on the one or two highest‑leverage factors rather than trying to optimize everything simultaneously.
How does Average Revenue Per User (ARPU) for HealthTech compare to cross‑industry benchmarks?
HealthTech Average Revenue Per User (ARPU) benchmarks can differ significantly from cross‑industry averages due to factors specific to the HealthTech vertical including customer acquisition dynamics, competitive intensity, and typical deal sizes. Always compare against industry‑specific benchmarks rather than broad averages for meaningful insights.

Get in touch

I read every message personally

Or reach me at [email protected]